#14: The Machine: Xenomics Announces License with Warnex of Acute Myeloid Leukemia Assay
Xenomics, Inc. (Pink Sheets:XNOM, FWB:XE7) announces that it has... |
February 28, 2008
12:44:00 AM |
#13: NewsBot: XNOM News Xenomics Names Key Pharmaceutical Industry Executive John Brancaccio to Board of Directors and to Audit Committee; Seasoned Financial and Biotechnology Professional Brings Experience in Commercialization of New Technologies
NEW YORK--(BUSINESS WIRE)--Dec. 6, 2005--Xenomics, Inc. (OTCBB:XNOM)(FWB:XE7), a... |
December 5, 2005
09:30:00 PM |
#12: NewsBot: XNOM News Xenomics to Present Breakthrough Medical DNA Technology at Rodman & Renshaw Techvest Healthcare Conference; Company to Outline Development of New Proprietary Transrenal-DNA Methods for Safe and Noninvasive Diagnosis of Diseases
NEW YORK--(BUSINESS WIRE)--Nov. 3, 2005--Xenomics, Inc. (OTCBB:XNOM)(FWB:XE7), a... |
November 2, 2005
09:30:00 PM |
#11: NewsBot: XNOM News Web Alert: Xenomics' Breakthrough DNA Technology to be Presented Today at Bio InvestorForum with Online Simulcast; CEO to Detail Revolutionary DNA Testing Technology Designed to Provide Noninvasive Diagnosis for Major Diseases
NEW YORK--(BUSINESS WIRE)--Oct. 20, 2005--Xenomics, Inc. (OTCBB: XNOM) (FSE: XE7),... |
October 19, 2005
08:30:00 PM |
#10: NewsBot: XNOM News Xenomics' Breakthrough Transrenal-DNA Technology Platform to be Presented at Bio InvestorForum in San Francisco; Revolutionary DNA Testing Technology Could Provide Completely Noninvasive Detection Alternative for Major Diseases
NEW YORK--(BUSINESS WIRE)--Oct. 11, 2005--Xenomics, Inc. (OTCBB:XNOM) (FWB:XE7), a... |
October 10, 2005
08:30:00 PM |
#9: NewsBot: XNOM News Xenomics' Research Partner to Make Special Presentation of Clinical Data at Prestigious World Conference on Lung Health; Leading International Health Organization Recognizes Breakthrough Potential of Xenomics Proprietary Transrenal-DNA Platform
NEW YORK--(BUSINESS WIRE)--Sept. 22, 2005--Xenomics, Inc. (OTCBB:XNOM), a... |
September 21, 2005
08:30:00 PM |
#8: NewsBot: XNOM News Xenomics' Novel Noninvasive Tr-DNA Technology Featured as Potential ``Amnio Alternative'' in Online News Article; Company CEO Dr. Randy White Discusses Breakthrough Medical Technology for Prenatal Diagnostic Testing in ``Herald News''
NEW YORK--(BUSINESS WIRE)--Sept. 8, 2005--Xenomics, Inc. (OTCBB:XNOM), a developer... |
September 7, 2005
11:00:00 PM |
#7: NewsBot: XNOM News Xenomics Featured in CNN Money Segment on its Development of Novel Noninvasive Prenatal Test to Detect Down Syndrome; CEO Dr. Randy White Discusses Development of Breakthrough Test Based on Proprietary Tr-DNA Technology in New Online Interview
NEW YORK--(BUSINESS WIRE)--Aug. 26, 2005--Xenomics, Inc. (OTCBB:XNOM), a developer... |
August 26, 2005
11:50:00 AM |
#6: NewsBot: XNOM News Webalert: Xenomics CEO Randy White to Field Questions Today in Online Discussion with American Assoc. of Clinical Chemistry; CEO to Discuss Company's Commercialization of Proprietary Diagnostic Platform Technology for Biomedical Marketplace
NEW YORK--(BUSINESS WIRE)--Aug. 9, 2005--Xenomics, Inc. (OTCBB:XNOM), a developer... |
August 8, 2005
11:00:00 PM |
#5: NewsBot: XNOM News Xenomics CEO Randy White to Present Tr-DNA in American Association of Clinical Chemistry Online Education Seminar; CEO to Field Questions on Company Plan to Commercialize Revolutionary Diagnostic Testing Technology During Interactive Program
NEW YORK--(BUSINESS WIRE)--Aug. 8, 2005--Xenomics, Inc. (OTCBB:XNOM), a developer... |
August 7, 2005
11:00:00 PM |
#4: NewsBot: XNOM News Xenomics CEO Dr. Randy White to Present Company's Tr-DNA Technology Platform and Market Outlook at Frankfurt Stock Day; Participation at Respected European Financial Conference Expected to Enhance Strategic Relationships in International Communi
NEW YORK--(BUSINESS WIRE)--Aug. 5, 2005--Xenomics, Inc. (OTCBB:XNOM), a developer... |
August 4, 2005
11:00:00 PM |
#3: NewsBot: XNOM News Xenomics Granted European Patent for Breakthrough Tr-DNA Technology to Detect Fetal Genetic Abnormalities; New Patent Further Strengthens Xenomics' Strategy to Create and Distribute New Medical Diagnostic Products for International Market
NEW YORK--(BUSINESS WIRE)--July 27, 2005--Xenomics, Inc. (OTCBB:XNOM), a developer... |
July 26, 2005
11:00:00 PM |
#2: NewsBot: XNOM News Xenomics to Present New Data Showing Improved Sensitivity for HIV Diagnostic Capabilities of Transrenal-DNA Technology; Company to Deliver Additional Data on Breakthrough Diagnostic Platform for HIV at AACC Meeting
Xenomics to Present New Data Showing Improved Sensitivity for HIV Diagnostic... |
July 22, 2005
06:45:40 AM |
#1: NewsBot: XNOM News Research Xenomics, Stock Trading Message Board
Xenomics Closes $2.77 Million Financing to Accelerate Development of Risk-Free... |
July 16, 2005
07:51:14 PM |
| 
| 
| 
| 
| 
| 
